Study offers insights into how pancreatic cancer develops

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis has revealed the details of two key transition points in the development of pancr

Updated on: December 18,2023

Study offers insights into how pancreatic cancer develops

byWashington University School of MedicineA new study from Washington University School of Medicine in St. Louis has revealed the details of two key transition points in the development of pancr

Updated on:December 18,2023

Researchers clarify role of SMYD3 enzyme in prostate cancer progression

by Sarah Hansen,University of Maryland Baltimore CountySMYD3 loss impedes PCa progression.(A) Expression ofSMYD3mRNA from TCGA [GTEX normal (n= 105), TCGA tumor adjacent normal

Updated on: December 26,2023

Researchers clarify role of SMYD3 enzyme in prostate cancer progression

by Sarah Hansen,University of Maryland Baltimore CountySMYD3 loss impedes PCa progression.(A) Expression ofSMYD3mRNA from TCGA [GTEX normal (n= 105), TCGA tumor adjacent normal

Updated on:December 26,2023

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

February 2024Lara C. Pullen, PhDResults from a contemporary standard-of-care study of patients with primary hemophagocytic lymphohistiocytosis (pHLH) reveal that firstline etoposide-based therapy is m

Updated on: February 18,2024

Survival in Primary Hemophagocytic Lymphohistiocytosis Can Be as High as 100%

February 2024Lara C. Pullen, PhDResults from a contemporary standard-of-care study of patients with primary hemophagocytic lymphohistiocytosis (pHLH) reveal that firstline etoposide-based therapy is m

Updated on:February 18,2024

The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network (HTAN) stands at the forefront of cancer research, representing a groundbreaking initiative funded by the National Cancer Institute (NCI) as part of the ambitious Cancer Moonshot℠ program. Launched in 2018, HTAN's primary mis

Updated on: November 07,2024

The Human Tumor Atlas Network: Mapping Cancer's Complexity and Evolution

The Human Tumor Atlas Network (HTAN) stands at the forefront of cancer research, representing a groundbreaking initiative funded by the National Cancer Institute (NCI) as part of the ambitious Cancer Moonshot℠ program. Launched in 2018, HTAN's primary mis

Updated on:November 07,2024

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on: December 26,2023

Developing therapies for treatment-resistant prostate cancer: Small clinical trial shows 40% progression-free survival

byCedars-Sinai Medical CenterGraphical abstract. Credit:Molecular Therapy(2022). DOI: 10.1016/j.ymthe.2022.08.019Investigators from Cedars-Sinai Cancer have identified an investigati

Updated on:December 26,2023

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer

Updated on: April 02,2024

Intravesical gemcitabine/docetaxel as an alternative therapy for patients with non-muscle-invasive bladder cancer

by Michael A. O'Donnell and Mohamad Abou Chakra , Medical XpressNMIBC: non-muscle invasive bladder cancer; BCG: Bacillus Calmette-Guérin; Gem: gemcitabine; Doce: docetaxel. Parts of the figure wer

Updated on:April 02,2024

Non-hormonal therapy reduces hot flashes and night sweats in women who have been diagnosed with breast cancer

by Cheryl Critchley,Monash UniversityCredit: Pixabay/CC0 Public DomainA Monash University-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flas

Updated on: December 22,2023

Non-hormonal therapy reduces hot flashes and night sweats in women who have been diagnosed with breast cancer

by Cheryl Critchley,Monash UniversityCredit: Pixabay/CC0 Public DomainA Monash University-led trial of a new drug known as Q-122 therapy significantly reduced the number and severity of hot flas

Updated on:December 22,2023

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Updated on: September 27,2024

Men often confused about prostate cancer screening, survey shows

by Ernie MundellA new survey finds the majority of American men believe the first step inprostate cancerscreening is an invasive rectal exam by their doctor.That's not true, but mistak

Updated on:September 27,2024

Uncovering how air pollution causes lung cancer

byCORDISCredit: AI-generated imageCigarette smoking is the No. 1 risk factor for lung cancer. Exposure to second-hand smoke can also increase the risk of lung cancer. This is what scientists hav

Updated on: December 26,2023

Uncovering how air pollution causes lung cancer

byCORDISCredit: AI-generated imageCigarette smoking is the No. 1 risk factor for lung cancer. Exposure to second-hand smoke can also increase the risk of lung cancer. This is what scientists hav

Updated on:December 26,2023

Unraveling predisposition in bilateral Wilms tumor

bySt. Jude Children's Research HospitalSummary of Proposed Mechanisms for Bilateral Wilms tumor development. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-43730-0Ch

Updated on: December 30,2023

Unraveling predisposition in bilateral Wilms tumor

bySt. Jude Children's Research HospitalSummary of Proposed Mechanisms for Bilateral Wilms tumor development. Credit:Nature Communications(2023). DOI: 10.1038/s41467-023-43730-0Ch

Updated on:December 30,2023

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Updated on: December 22,2023

Structural analysis reveals an unexpected mechanism for a cancer drug

by Tim Stephens,University of California - Santa CruzThe breast cancer drug palbociclib (grey) interacts with its target protein CDK4 (green) in this structural model. Binding of the activator p

Updated on:December 22,2023

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

Updated on: December 18,2023

3-D mammography detected 34% more breast cancers in screening

byLund UniversityUsing breast tomosynthesis (3D screening) in the image to the left (one of about 50 thin cross-sectional image slices of the breast), you can see an approximately 1 cm-large tum

Updated on:December 18,2023